Insider · CIK 0001595261
Douglas N. Armer
Files at North Haven Net REIT. First filing Jan 27, 2025, latest Jan 27, 2025.
In brief
Douglas N. Armer files SEC Form 4 as CFO at North Haven Net REIT. Since Jan 27, 2025, Douglas N. Armer has reported 1 open-market buy worth $500k and 0 open-market sells worth $0, the latest filed on Jan 27, 2025.
A track record needs three past buys with six months of prices behind them; Douglas N. Armer has 0, so none is measured yet.
The newest scored trade: bought $500k of North Haven Net REIT on Apr 1, 2024, filed Jan 27, 2025, scored 63 (notable).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | -buy 4 North Haven Net REIT | $500k 25,000 shares | - | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | - North Haven Net REIT | POpen-market purchase Class E Common Shares | +25,000 | $20.00 | $500k | 25,000 | Jan 27, 2025 |
Questions about Douglas N. Armer
Answered from the filings on this page, as of the latest one.
Is Douglas N. Armer buying or selling?
Not in the last 12 months. Douglas N. Armer's latest open-market trade on SEC Form 4 was bought $500k of North Haven Net REIT on Apr 1, 2024.
How did Douglas N. Armer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas N. Armer has 0.
Where does Douglas N. Armer file Form 4?
Douglas N. Armer has filed Form 4 at North Haven Net REIT as CFO & Head of Capital Markets. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.